South Africa has become only the second country in the world to allow widespread access to groundbreaking HIV pre-exposure prophylaxis medication.
South Africa lost nearly 100 000 people to TB last year – three-quarters of whom were HIV-positive. Reducing the burden will benefit the economy.
Our failure to adequately engage men with health services reduces the effectiveness of the many impressive, new HIV prevention breakthroughs.
The Treatment Action Campaign believes antiretroviral treatment should be offered to all HIV-positive citizens, not just those with low CD4 counts.
Hospitals throughout Gauteng ran out of essential medicines in recent weeks, including a life-saving drug for people with Aids called Amphotericin B.
A French team of scientists have proposed a process called "endogenisation", believed to have neutralised other viruses in humans in the past.
DA leader Helen Zille has once again sparked controversy over her views on HIV and Aids.
Experts say more focus on early treatment rather than waiting for CD4 counts will dramatically reduce viral replication and new infections.
The drug previously showed it can activate hidden HIV in the cells. Now it shows it can activate the virus, making it traceable by the immune system.
While 75% of people who inject drugs live in middle-income countries, funding for Aids prevention for these people is in crisis, experts have warned.
Research suggests that taking HIV medication while CD4 counts are higher than 350 does not reduce mortality in those who are co-infected.
Thandi Modise says she is concerned over reports that intimidation has stopped miners from accessing health services in the platinum belt.
While much has been done to end Aids in Africa, more work by governments is necessary to move forward, particularly in SA.
Although it has been claimed that a nine-month-old baby in California was "cured" from HIV with the use of antiretrovirals, there is still no proof.
A single shot of antiretroviral drugs has protected lab monkeys from HIV for weeks, according to two US trials.
According to a study, the discovery of how a woman's body responded to her HIV infection by making antibodies may hold the clue to a cure for Aids.
We feature four HIV positive women in their 40s who fit the profile of a typical M&G reader.